UAMY insider sale: 40,000 shares at $6.44 by director
United States Antimony Corp (UAMY) director and officer Lloyd Bardswich reported a sale of 40,000 shares of the company's common stock on 09/29/2025 at a price of $6.44 per share.
Rhea-AI Filing Summary
United States Antimony Corp (UAMY) director and officer Lloyd Bardswich reported a sale of 40,000 shares of the company's common stock on 09/29/2025 at a price of $6.44 per share. After the sale the filing shows beneficial ownership listed as 594.047 (as reported). The Form 4 was signed by the reporting person on 10/04/2025. No derivative transactions or additional purchases were disclosed.
Positive
- None.
Negative
- Director/officer sold 40,000 shares on 09/29/2025 at $6.44 per share
Insights
Insider sale of 40,000 shares at $6.44.
The Form 4 shows that Lloyd Bardswich, a director and executive officer, disposed of 40,000 common shares on 09/29/2025 at $6.44 per share.
This filing documents a straightforward open-market sale; the form does not state any 10b5-1 plan or reason for the sale, and no derivative activity was reported.
If investors track insider activity, this is a clear, single-event disposition recorded by a senior insider.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 40,000 | $6.44 | $258K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UAMY insider Lloyd Bardswich report on the Form 4?
When was the Form 4 signed for the UAMY transaction?
Does the Form 4 show any derivative transactions for UAMY by this insider?
What is the reported beneficial ownership after the transaction?
Was this sale reported as part of a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.